Equities

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

$254.2bn
Equities Assets Under Management

155
Equities Investment
Professionals

18
Average Years’
Experience

As at September 30, 2025

$254.2bn
Equities Assets Under Management

155
Equities Investment
Professionals

18
Average Years’
Experience

As at September 30, 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

International Alpha

Invests in international companies where we believe the market underestimates free-cash-flow growth, with the aim to derive independent and uncorrelated sources of alpha.

Global Alpha Equity

By investing in global companies across the market-cap and style spectrum, we seek to deliver consistently good risk-adjusted returns, not sporadically great results.

Biotechnology Innovation

A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments.